A carregar...
Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
PURPOSE: To evaluate the effectiveness of alcaftadine 0.05%, 0.1%, and 0.25% ophthalmic solutions in treating the signs and symptoms of allergic conjunctivitis when compared with olopatadine hydrochloride 0.1% and placebo using the conjunctival allergen challenge (CAC) model. METHODS: One hundred an...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3037035/ https://ncbi.nlm.nih.gov/pubmed/21339800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S15379 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|